SurBred 15 antigen-based blood test not subject to FDA regulation
Company: Riot
The claim, verbatim
The antigen-based blood test for SurBred 15 is not subject to FDA regulation
Source (primary)
Riot SB-2 filed 2004-09-14 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “The antigen-based blood test is not subject to FDA regulation.”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The filing states that the SurBred 15 antigen-based blood test is not subject to FDA regulation.
Confirmed in the source:
- The antigen-based blood test for SurBred 15 is not subject to FDA regulation
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997304000468/aspenbio_sb2.txt) in full (272,234 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot SB-2 filed 2004-09-14
Quote: “The antigen-based blood test is not subject to FDA regulation.”